Xarelto Lawsuits Menu

Receive a Free
Legal Consultation

  • This field is for validation purposes and should be left unchanged.

Simmons Hanly Conroy lawyers are currently investigating serious bleeding incidents in the brain and gastrointestinal track linked to the use of Xarelto, an alternative oral anticoagulant drug prescribed to prevent blood clots.

Xarelto bleeding lawsuits are now being filed against Bayer and Jassen Pharmaceuticals as a result of serious uncontrollable bleeding incidents experienced by patients. Unlike Warfin, the traditional blood thinning drug, there is no current reversal agent for Xarelto, making it a particularly dangerous drug.

The Xarelto lawyers, led by named shareholders Paul Hanly and Jayne Conroy, at Simmons Hanly Conroy are currently investigating the serious and potentially fatal side effects linked to Xarelto. If you or a loved one has experienced serious bleeding incidents or other serious side effects linked to Xarelto, please contact us. You may be eligible to file a Xarelto lawsuit.

What is Xarelto?

Xarelto was approved by the U.S. Food & Drug in 2011 to treat the following:

  • Reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem.
  • Treat deep vein thrombosis and pulmonary embolism.
  • Reduce the risk of forming a blood clot in the legs and lungs of adults recovering from knee or hip surgery.

Xarelto was invented and manufactured by Bayer before 2008. In the United States, it is marketed by Jassen Pharmaceuticals, a division of Johnson & Johnson, as an alternative to Warfin because Xarelto does not require blood monitoring. However, many users have found that the convenience of Xarelto does not warrant its risk of serious side effects.

Xarelto Drug Safety Alerts

The Institute for Safe Medication Practices, an independent health nonprofit group that monitors FDA MedWatch Reports, has called anticoagulant drugs, like Xarelto and Pradaxa, “a high-risk treatment that causes bleeding in approximately 15 percent of patients with atrial fibrillation exposed for a year.”

In 2012, the FDA received hundreds of reports of adverse effects in Xarelto users. In Q1 of 2013, 638 adverse reports linked to Xarelto use were submitted through the FDA’s MedWatch Reporting System. ISMP cited the increase to more prescriptions of Xarelto being dispensed. However, it stressed that the safety of anticoagulant drugs remains a major concern given the high risks of bleeding and increased use.

Because of Xarelto’s increased risk of uncontrollable bleeding, the FDA rejected a bid from Bayer and J&J to approve the drug for use in prevention of new heart attacks and strokes in patients with acute coronary syndrome. According to Reuters, FDA panel members said the benefit of the drug was not shown to outweigh an increased risk of bleeding.

Xarelto Bleeding Side Effects

Xarelto can cause serious bleeding because of how it affects blood clotting proteins. Notify your doctor immediately if you notice any of the following signs of serious bleeding while taking Xarelto:

  • Unusual pain, swelling or discomfort
  • Unusual bruising
  • Prolonged bleeding from cuts or gums
  • Persistent and/or frequent nose bleeds
  • Unusually heavy or prolonged menstrual flow
  • Coughing up blood
  • Dark urine and/or tarry stools
  • Vomit that is blood or looks like coffee grounds
  • Severe headache, dizziness or fainting
  • Unusual or persistent tiredness and fatigue
  • Difficulty swallowing

Xarelto Legal Consultation

Shareholder Jayne Conroy co-leads the pharmaceutical attorneys.

Shareholder Jayne Conroy co-leads the pharmaceutical attorneys.

The Xarelto lawyers at Simmons Hanly Conroy are investigating the legal rights of people who suffered significant injuries while taking Xarelto. The drug companies responsible for Xarelto may have failed in their duty to adequately warn consumers about the increased risk of bleeding events compared to other anticoagulant drugs.

Contact us for more information regarding your specific situation. Our experienced Xarelto lawyers will evaluate your case, answer your questions and help you understand your legal rights in regards to filing a Xarelto lawsuit.

Xarelto Injury Links

ISMP QuarterWatch 2013 Q1 on Anticoagulant drugs

FDA rejects wider use of Xarelto drug
Reuters, Feb. 14, 2014

FDA Letter to J&J for Misleading Advertising regarding Xarelto

Xarelto Safety Information
U.S. Food & Drug Administration

Client Testimonials

I give thanks to the Simmons firm. I am so grateful. It seems like when something happens, like my roof or chimney leaking, we now have the funds.

View More Testimonials

- Elizabeth
Wife of Frederick, Client

166 queries. 0.645 seconds